Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Molly Downhour"'
Autor:
Gayle S. Jameson, Ramesh K. Ramanathan, Mitesh J. Borad, Molly Downhour, Ronald Korn, Daniel Von Hoff
Publikováno v:
Case Reports in Gastroenterology, Vol 3, Iss 1, Pp 67-71 (2009)
Marantic endocarditis, otherwise known as nonbacterial thrombotic endocarditis (NBTE), is a well-documented phenomenon due to hypercoagulability from an underlying cause. It has been associated with a variety of inflammatory states including malignan
Externí odkaz:
https://doaj.org/article/b4e66db57c774221bca56081272deff1
Autor:
Glen J. Weiss, Raoul Tibes, Lisa Blaydorn, Gayle Jameson, Molly Downhour, Erica White, Ivor Caro, Daniel D. Von Hoff
Publikováno v:
Dermatology Reports, Vol 3, Iss 3, Pp e55-e55 (2011)
Tumor responses in advanced basal cell carcinoma (BCC) have been observed in clinical trials with vismodegib, a SMO antagonist. The result of SMO antagonism is inhibition Hedgehog Signaling Pathway (HHSP) downstream target genes. HHSP inhibition has
Externí odkaz:
https://doaj.org/article/c84cf0cfbb1043739bf6c7c1e6954abb
Autor:
Daniel D. Von Hoff, Erica White, Glen J. Weiss, Ramesh K. Ramanathan, Alexandra Mckane, Molly Downhour, Chao Sima, Sharon Fleck, Cathy Mast, Gayle S. Jameson
Publikováno v:
Investigational New Drugs. 31:774-779
Objective Certain eligibility criteria for Phase 1 cancer clinical trials may impede successful patient enrollment onto a study. We evaluated patient-specific or study-specific reasons for screen failures on Phase 1 oncology clinical trials and discu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::439d9b39c1284d5563dcfb14377c574a
https://doi.org/10.1007/s10637-012-9894-7
https://doi.org/10.1007/s10637-012-9894-7
Autor:
Glen J. Weiss, Molly Downhour, Ronald L. Korn, Raoul Tibes, Curtis Thacker, Erica White, Lisa Blaydorn, Jason Baldwin, Daniel D. Von Hoff
Publikováno v:
Cancer Medicine
The use of 18-fluorodeoxyglucose (FDG) positron emission tomography with computed tomography (PET/CT) in subjects with advanced basal cell carcinoma (BCC) has not been fully explored due to the rarity of disease presentation. This study evaluated PET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ac50d9841ab96ed823f77ee1d8d1cb8
https://doi.org/10.1002/cam4.33
https://doi.org/10.1002/cam4.33
Autor:
Mitesh J. Borad, Ronald L. Korn, Ramesh K. Ramanathan, Gayle S. Jameson, Molly Downhour, Daniel D. Von Hoff
Publikováno v:
Case Reports in Gastroenterology
Case Reports in Gastroenterology, Vol 3, Iss 1, Pp 67-71 (2009)
Case Reports in Gastroenterology, Vol 3, Iss 1, Pp 67-71 (2009)
Marantic endocarditis, otherwise known as nonbacterial thrombotic endocarditis (NBTE), is a well-documented phenomenon due to hypercoagulability from an underlying cause. It has been associated with a variety of inflammatory states including malignan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa62e30a8b148939fe51cdc1c3bf5380
https://doi.org/10.1159/000207195
https://doi.org/10.1159/000207195
Autor:
Lisa Blaydorn, Ivor Caro, Erica White, Glen J. Weiss, Gayle S. Jameson, Daniel D. Von Hoff, Molly Downhour, Raoul Tibes
Publikováno v:
Dermatology Reports
Dermatology Reports, Vol 3, Iss 3, Pp e55-e55 (2011)
Dermatology Reports, Vol 3, Iss 3, Pp e55-e55 (2011)
Tumor responses in advanced basal cell carcinoma (BCC) have been observed in clinical trials with vismodegib, a SMO antagonist. The result of SMO antagonism is inhibition Hedgehog Signaling Pathway (HHSP) downstream target genes. HHSP inhibition has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f6d5a97a0950bb00038a23e0685267e
http://europepmc.org/articles/PMC4211514
http://europepmc.org/articles/PMC4211514
Autor:
Molly Downhour, Gayle S. Jameson, Ramesh K. Ramanathan, Daniel D. Von Hoff, Cathy Mast, Frederic Zenhausern, Stephen P. Rogers, Glen J. Weiss, Manpreet K. Chadha, Erica White
Publikováno v:
Cancer Research. 72:1264-1264
Introduction Analysis of biological samples for volatile organic compound (VOC) profiles or fingerprints can potentially be utilized as a non-invasive, early stage diagnostic tool for disease related to metabolic processes. A hypothesis was presented
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeebd68cd3b07b75c81165c40da7a544
https://doi.org/10.1158/1538-7445.am2012-1264
https://doi.org/10.1158/1538-7445.am2012-1264